Companies with a Health score of at least 4, ordered by Health score.
Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom.
Physiomics Plc provides outsourced systems and computational biology services to pharmaceutical companies in the United Kingdom, the European Union, and the United States.
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapies for the treatment of respiratory diseases with unmet medical needs.
Evgen Pharma plc, a clinical stage drug development company, focuses on the treatment of cancer and neurological diseases.
ReNeuron Group plc develops and sells cell-based therapies in the United Kingdom.
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom.
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia.
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People’s Republic of China and Hong Kong.
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally.
Horizon Discovery Group plc, a translational genomics company, develops and supplies patient-relevant drug discovery and diagnostic reference standards in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.
MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally.
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide.
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of hospital-focused pharmaceuticals to treat unmet medical needs.
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide.
Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide.
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products.